Pulse 探索 nav.journalClub 議論トレンド研究者

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

ホーム探索 nav.journalClub トレンド

⌘+K

EANM guideline on the validation of analytical methods for radiopharmaceuticals | Synapse

February 12, 2020Open Access

放射性医薬品の分析手法の検証に関するEANMガイドライン

Key Points

Key points are not available for this paper at this time.

Abstract

適正製造基準に従うために、人間用の放射性医薬品の分析手法は検証されるべきである。

AIに質問

Like

Bookmark

Share

View Full Paper

Cite This Study

Gillings et al. (Wed,) はこの問題について研究した。

synapsesocial.com/papers/69d56c2f75589c71d767cc7d https://doi.org/https://doi.org/10.1186/s41181-019-0086-z

AIに質問

Like

Bookmark

Share

View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Direct analysis of Kryptofix 2.2.2 in 18FDG by gas chromatography using a nitrogen-selective detector1993 · 21 citations
2Retention of [18F]fluoride on reversed phase HPLC columns2015 · 56 citations
3Development and Successful Validation of Simple and Fast TLC Spot Tests for Determination of Kryptofix® 2.2.2 and Tetrabutylammonium in 18F-Labeled Radiopharmaceuticals2014 · 39 citations
4Thin layer chromatographic detection of Kryptofix 2.2.2 in the routine synthesis of [18F]2-fluoro-2-deoxy-d-glucose1989 · 40 citations
5Removal of the 2.2.2 cryptand (kryptofix 2.2.2™) from 18FDG by cation exchange1991 · 23 citations